TABLE 2.
Serum biochemical markers and hepatic lipids levels after 12 weeks.
| Sample | Parameters | NC | HFD | LBLFL (50 mg/kg⋅bw) | LBLFM (100 mg/kg⋅bw) | LBLFH (200 mg/kg⋅bw) |
| Serum | TC (mmol/L) | 4.89 ± 0.46** | 9.65 ± 0.35## | 9.21 ± 0.44## | 7.16 ± 0.62##* | 6.21 ± 0.51#** |
| TG (mmol/L) | 0.95 ± 0.08** | 2.14 ± 0.19## | 1.82 ± 0.36## | 1.56 ± 0.11##** | 1.41 ± 0.21#** | |
| HDL-C (mmol/L) | 3.69 ± 0.17** | 1.89 ± 0.22## | 2.52 ± 0.64##* | 2.75 ± 0.22##* | 3.33 ± 0.16** | |
| LDL-C (mmol/L) | 0.82 ± 0.34** | 1.97 ± 0.14## | 1.54 ± 0.19##* | 1.37 ± 0.24#* | 1.02 ± 0.24** | |
| Glucose (mmol/L) | 3.7 ± 0.29** | 8.1 ± 0.32## | 7.4 ± 0.77##* | 5.4 ± 0.68##** | 4.8 ± 0.49##** | |
| NEFA (μmol/L) | 276.42 ± 47.79** | 657.20 ± 61.11## | 548.52 ± 50.87##* | 527.48 ± 56.77##* | 456.51 ± 59.82##** | |
| AST (U/L) | 97.23 ± 9.96** | 186.87 ± 11.26## | 165.33 ± 7.18##* | 142.65 ± 8.91##** | 122.77 ± 12.89#** | |
| ALT (U/L) | 41.73 ± 5.99** | 116.37 ± 10.11## | 107.47 ± 10.49## | 84.33 ± 5.72##** | 61.17 ± 3.94#** | |
| Liver | TC (μmol/g liver wt) | 13.65 ± 3.10** | 41.82 ± 7.36## | 35.66 ± 5.12## | 28.85 ± 5.98##* | 20.58 ± 4.67** |
| TG (μmol/g liver wt) | 33.59 ± 3.31** | 65.57 ± 4.62## | 63.88 ± 6.69## | 53.82 ± 3.78##** | 44.36 ± 3.17#** |
#p < 0.05 and ##p < 0.01 vs. NC group; *p < 0.05 and **p < 0.01 vs. HFD group.